Sharp Invests More into Enhancing IRT Solution


Applied Clinical Trials

Sharp-part of UDG Healthcare plc, a global company in contract packaging and clinical supply services-announced that it is investing $650,000 into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots, and investigative sites.

To read the full release, click here.




Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.